Centogene announces voting results of extraordinary general meeting

Cambridge, mass. and rostock, germany and berlin, feb. 22, 2022 (globe newswire) -- centogene n.v. (nasdaq: cntg), a commercial-stage company focused on generating data-driven insights to diagnose, understand, and treat rare diseases, today announced the voting results of the company's extraordinary general meeting. the shareholders of the company voted in favor of all proposals, which included the appointments of kim stratton as managing director and prof. andreas busch as supervisory director.
CNTG Ratings Summary
CNTG Quant Ranking